Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2
- PMID: 22999129
- PMCID: PMC4207095
- DOI: 10.1016/j.jval.2012.06.016
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2
Abstract
The appropriate development of a model begins with understanding the problem that is being represented. The aim of this article was to provide a series of consensus-based best practices regarding the process of model conceptualization. For the purpose of this series of articles, we consider the development of models whose purpose is to inform medical decisions and health-related resource allocation questions. We specifically divide the conceptualization process into two distinct components: the conceptualization of the problem, which converts knowledge of the health care process or decision into a representation of the problem, followed by the conceptualization of the model itself, which matches the attributes and characteristics of a particular modeling type with the needs of the problem being represented. Recommendations are made regarding the structure of the modeling team, agreement on the statement of the problem, the structure, perspective, and target population of the model, and the interventions and outcomes represented. Best practices relating to the specific characteristics of model structure and which characteristics of the problem might be most easily represented in a specific modeling method are presented. Each section contains a number of recommendations that were iterated among the authors, as well as among the wider modeling taskforce, jointly set up by the International Society for Pharmacoeconomics and Outcomes Research and the Society for Medical Decision Making.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2.Med Decis Making. 2012 Sep-Oct;32(5):678-89. doi: 10.1177/0272989X12454941. Med Decis Making. 2012. PMID: 22990083
-
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.Value Health. 2012 Sep-Oct;15(6):796-803. doi: 10.1016/j.jval.2012.06.012. Value Health. 2012. PMID: 22999128
-
Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4.Value Health. 2012 Sep-Oct;15(6):821-7. doi: 10.1016/j.jval.2012.04.013. Value Health. 2012. PMID: 22999131
-
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.Med Decis Making. 2012 Sep-Oct;32(5):667-77. doi: 10.1177/0272989X12454577. Med Decis Making. 2012. PMID: 22990082 Review.
-
Selecting a dynamic simulation modeling method for health care delivery research-part 2: report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force.Value Health. 2015 Mar;18(2):147-60. doi: 10.1016/j.jval.2015.01.006. Value Health. 2015. PMID: 25773550 Review.
Cited by
-
Cost Analysis of Pure Hypochlorous Acid Preserved Wound Cleanser versus Mafenide for the Irrigation of Burn Wounds.Clinicoecon Outcomes Res. 2024 Oct 16;16:747-752. doi: 10.2147/CEOR.S476201. eCollection 2024. Clinicoecon Outcomes Res. 2024. PMID: 39430729 Free PMC article.
-
The Impact of Wildfire Smoke on Asthma Control in California: A Microsimulation Approach.Geohealth. 2024 Oct 4;8(10):e2024GH001037. doi: 10.1029/2024GH001037. eCollection 2024 Oct. Geohealth. 2024. PMID: 39371245 Free PMC article.
-
The conceptualisation of cardiometabolic disease policy model in the UK.BMC Health Serv Res. 2024 Sep 13;24(1):1060. doi: 10.1186/s12913-024-11559-y. BMC Health Serv Res. 2024. PMID: 39272116 Free PMC article.
-
Cost-Effectiveness of Plasma Microbial Cell-Free DNA Sequencing When Added to Usual Care Diagnostic Testing for Immunocompromised Host Pneumonia.Pharmacoeconomics. 2024 Sep;42(9):1029-1045. doi: 10.1007/s40273-024-01409-4. Epub 2024 Jul 2. Pharmacoeconomics. 2024. PMID: 38955978 Free PMC article.
-
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.Pharmacoeconomics. 2024 Jun;42(6):693-714. doi: 10.1007/s40273-024-01385-9. Epub 2024 Apr 29. Pharmacoeconomics. 2024. PMID: 38684631 Free PMC article.
References
-
- Caro JJ, Briggs AH, Siebert U, et al. Modeling good research practices— overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Value Health. 2012;15:796–803. - PubMed
-
- Siebert U, Alagoz O, Bayoumi AM, et al. State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3. Value Health. 2012;15:812–820. - PubMed
-
- Karnon J, Stahl J, Brennan A, et al. Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4. Value Health. 2012;15:821–827. - PubMed
-
- Briggs AH, Weinstein M, Fenwick E, et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6. Value Health. 2012;15:835–842. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
